175 related articles for article (PubMed ID: 36396603)
1. Blood levels of MCP-1 modulate the genetic risks of Alzheimer's disease mediated by HLA-DRB1 and APOE for Alzheimer's disease.
Huang J; Stein TD; Wang Y; Ang TFA; Tao Q; Lunetta KL; Massaro J; Akhter-Khan SC; Mez J; Au R; Farrer LA; Zhang X; Qiu WQ;
Alzheimers Dement; 2023 May; 19(5):1925-1937. PubMed ID: 36396603
[TBL] [Abstract][Full Text] [Related]
2. The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer's disease.
Huang J; Tao Q; Ang TFA; Farrell J; Zhu C; Wang Y; Stein TD; Lunetta KL; Massaro J; Mez J; Au R; Farrer LA; Qiu WQ; Zhang X;
Transl Psychiatry; 2022 Dec; 12(1):523. PubMed ID: 36550123
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA-DRB1 polymorphism with Alzheimer's disease: a replication and meta-analysis.
Lu RC; Yang W; Tan L; Sun FR; Tan MS; Zhang W; Wang HF; Tan L
Oncotarget; 2017 Nov; 8(54):93219-93226. PubMed ID: 29190991
[TBL] [Abstract][Full Text] [Related]
4. Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease.
Panitch R; Hu J; Xia W; Bennett DA; Stein TD; Farrer LA; Jun GR
Alzheimers Res Ther; 2022 Feb; 14(1):30. PubMed ID: 35139885
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
Wolk DA; Dickerson BC;
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
[TBL] [Abstract][Full Text] [Related]
7. APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies.
Wang T; Huynh K; Giles C; Mellett NA; Duong T; Nguyen A; Lim WLF; Smith AA; Olshansky G; Cadby G; Hung J; Hui J; Beilby J; Watts GF; Chatterjee P; Martins I; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Taddei K; Doré V; Fripp J; Arnold M; Kastenmüller G; Nho K; Saykin AJ; Baillie R; Han X; Martins RN; Moses EK; Kaddurah-Daouk R; Meikle PJ
Alzheimers Dement; 2022 Nov; 18(11):2151-2166. PubMed ID: 35077012
[TBL] [Abstract][Full Text] [Related]
8. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.
Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D
Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468
[TBL] [Abstract][Full Text] [Related]
9. Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.
Hackenhaar FS; Josefsson M; Adolfsson AN; Landfors M; Kauppi K; Hultdin M; Adolfsson R; Degerman S; Pudas S
Alzheimers Res Ther; 2021 Jul; 13(1):130. PubMed ID: 34266503
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in the effect of APOE-ε4 genotypes on trail making test B in Alzheimer's disease: A longitudinal study.
Xu C; Acevedo P; Lu Y; Su BB; Ozuna K; Padilla V; Karithara A; Mao C; Navia RO; Piamjariyakul U; Wang K;
Int J Geriatr Psychiatry; 2023 Dec; 38(12):e6037. PubMed ID: 38100638
[TBL] [Abstract][Full Text] [Related]
12. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
13. Reassessing Diabetes and APOE Genotype as Potential Interacting Risk Factors for Alzheimer's Disease.
Ravipati K; Chen Y; Manns JR
Am J Alzheimers Dis Other Demen; 2022; 37():15333175211070912. PubMed ID: 35041557
[No Abstract] [Full Text] [Related]
14. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
[TBL] [Abstract][Full Text] [Related]
15. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
[TBL] [Abstract][Full Text] [Related]
16. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
Chen Q; Wang T; Kang D; Chen L
Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
[TBL] [Abstract][Full Text] [Related]
18. Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.
Kennedy RE; Cutter GR; Schneider LS
Alzheimers Dement; 2014 May; 10(3):349-59. PubMed ID: 23712001
[TBL] [Abstract][Full Text] [Related]
19. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
Dunk MM; Driscoll I;
J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
[TBL] [Abstract][Full Text] [Related]
20. Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer's Disease.
Zverova M; Kitzlerova E; Fisar Z; Jirak R; Hroudova J; Benakova H; Lelkova P; Martasek P; Raboch J
Curr Alzheimer Res; 2018; 15(10):938-950. PubMed ID: 29852871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
